Skip to main content
23 November 2024
Last updated:
Friday 22 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Biotechs post higher values in 2016 fourth quarter
Read more
Market Commentary: How risky are European biotechs?
Read more
The stately progress of antibiotics
Read more
Global oncology has many first-in-class compounds
Read more
Cheap capital gives rise to integrated pharma R&D
Read more
Commentary: Thought disruption in R&D discovery
Read more
Market Analysis: The outlook for European pharma
Read more
New risk capital for European companies
Read more
A strategy for treating traumatic brain injury
Read more
Treating the immune system, not the tumour
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
39
Page
40
Page
41
Page
42
Current page
43
Page
44
Page
45
Page
46
Page
47
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
